Redmile Group, LLC - Mar 31, 2025 SCHEDULE 13G/A Report for Immunome, Inc. Common Stock, $0.0001 Par Value (IMNM)

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Redmile Group, LLC	6.2%	5.36M	5.36M	/s/ Jeremy C. Green	Managing Member
Jeremy C. Green	6.2%	5.36M	5.36M	/s/ Jeremy C. Green	Jeremy C. Green
Redmile Biopharma Investments III, L.P.	4.5%	3.88M	3.88M	/s/ Jeremy C. Green	Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.

Showing 1 to 3 of 3 entries